These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 9544945)
21. Characterization of maltose and maltotriose transport in the acarbose-producing bacterium Actinoplanes sp. Brunkhorst C; Schneider E Res Microbiol; 2005 Sep; 156(8):851-7. PubMed ID: 15939574 [TBL] [Abstract][Full Text] [Related]
22. Pentagastrin-stimulated gastric acid output and plasma enteroglucagon in acarbose-treated rats. Rolston R; Ghiglione M; Bacarese-Hamilton AJ; Uttenthal LO; Bloom SR Digestion; 1985; 32(2):124-7. PubMed ID: 3899816 [TBL] [Abstract][Full Text] [Related]
23. Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes. Welborn TA Med J Aust; 1998 Jan; 168(2):76-8. PubMed ID: 9469188 [No Abstract] [Full Text] [Related]
24. Effect of alpha-amylase and alpha-glucosidase inhibitors on caries incidence and plaque accumulation in rats. Mörmann JE; Schmid R; Mühlemann HR Caries Res; 1983; 17(4):353-6. PubMed ID: 6191863 [No Abstract] [Full Text] [Related]
25. The mechanism of alpha-glucosidase inhibition in the management of diabetes. Bischoff H Clin Invest Med; 1995 Aug; 18(4):303-11. PubMed ID: 8549017 [TBL] [Abstract][Full Text] [Related]
26. [Effect of inhibition of intestinal glucosidase on protein and energy balance in rats]. Kirchgessner M; Spoerl R; Roth FX Ann Nutr Metab; 1981; 25(3):194-200. PubMed ID: 7025747 [TBL] [Abstract][Full Text] [Related]
27. Identification, cloning, expression, and characterization of the extracellular acarbose-modifying glycosyltransferase, AcbD, from Actinoplanes sp. strain SE50. Hemker M; Stratmann A; Goeke K; Schröder W; Lenz J; Piepersberg W; Pape H J Bacteriol; 2001 Aug; 183(15):4484-92. PubMed ID: 11443082 [TBL] [Abstract][Full Text] [Related]
28. Comprehensive proteome analysis of Actinoplanes sp. SE50/110 highlighting the location of proteins encoded by the acarbose and the pyochelin biosynthesis gene cluster. Wendler S; Otto A; Ortseifen V; Bonn F; Neshat A; Schneiker-Bekel S; Walter F; Wolf T; Zemke T; Wehmeier UF; Hecker M; Kalinowski J; Becher D; Pühler A J Proteomics; 2015 Jul; 125():1-16. PubMed ID: 25896738 [TBL] [Abstract][Full Text] [Related]
29. [Acarbose--a new therapeutic principle in diabetes mellitus therapy]. Schöffling K; Hillebrand I Dtsch Med Wochenschr; 1981 Aug; 106(35):1083-4. PubMed ID: 6114844 [No Abstract] [Full Text] [Related]
30. [A comparative study of the effect of inhibitors of microbial origin on different alpha-glucosidases]. Akulova NIu; Kazanina GA; Selezneva AA Prikl Biokhim Mikrobiol; 1994; 30(1):83-7. PubMed ID: 8146113 [TBL] [Abstract][Full Text] [Related]
31. The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats. Madar Z J Nutr; 1989 Dec; 119(12):2023-9. PubMed ID: 2695605 [TBL] [Abstract][Full Text] [Related]
32. Kinetic study of the inhibition of the honeybee haemolymph apha-glucosidase in vitro by BAYe 4609, BAYg 5421 and BAYn 5595. Bounias M Biochem Pharmacol; 1982 Sep; 31(17):2769-75. PubMed ID: 6215920 [TBL] [Abstract][Full Text] [Related]
33. A sensitive analytical apparatus for measuring hydrogen production rates. I. Application to studies in small animals. Evidence of the effects of an alpha-glucosidehydrolase inhibitor in the rat. Ostrander CR; Stevenson DK; Neu J; Kerner JA; Moses SW Anal Biochem; 1982 Jan; 119(2):378-86. PubMed ID: 7041699 [No Abstract] [Full Text] [Related]
34. Computer-aided molecular design of novel glucosidase inhibitors for AIDS treatment. Silva CH; Taft CA J Biomol Struct Dyn; 2004 Aug; 22(1):59-63. PubMed ID: 15214806 [TBL] [Abstract][Full Text] [Related]
35. The MalR type regulator AcrC is a transcriptional repressor of acarbose biosynthetic genes in Actinoplanes sp. SE50/110. Wolf T; Droste J; Gren T; Ortseifen V; Schneiker-Bekel S; Zemke T; Pühler A; Kalinowski J BMC Genomics; 2017 Jul; 18(1):562. PubMed ID: 28743243 [TBL] [Abstract][Full Text] [Related]
36. Clinical, endocrine and metabolic effects of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance. Ciotta L; Calogero AE; Farina M; De Leo V; La Marca A; Cianci A Hum Reprod; 2001 Oct; 16(10):2066-72. PubMed ID: 11574493 [TBL] [Abstract][Full Text] [Related]
37. Molecular structure of a barley alpha-amylase-inhibitor complex: implications for starch binding and catalysis. Kadziola A; Søgaard M; Svensson B; Haser R J Mol Biol; 1998 Apr; 278(1):205-17. PubMed ID: 9571044 [TBL] [Abstract][Full Text] [Related]
39. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method. Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657 [TBL] [Abstract][Full Text] [Related]
40. Comparative proteome analysis of Actinoplanes sp. SE50/110 grown with maltose or glucose shows minor differences for acarbose biosynthesis proteins but major differences for saccharide transporters. Wendler S; Otto A; Ortseifen V; Bonn F; Neshat A; Schneiker-Bekel S; Wolf T; Zemke T; Wehmeier UF; Hecker M; Kalinowski J; Becher D; Pühler A J Proteomics; 2016 Jan; 131():140-148. PubMed ID: 26597626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]